This isn’t an exhaustive list, but I typically help companies with:
- Guidance on converting a drug molecule into a developable Solid State version.
- Knowledge based selection of CROs for Solid State and Crystallisation.
- Capability build to provide a credible service in Solid State and Crystallisation.
- All aspects of Solid State and Crystallisation development and problem solving from pre-clinical to commercialisation including regulatory.
- Due diligence to flag risks and provide mitigation plans on asset transfer.
- Provision of expert opinion in support of Intellectual Property claims.
How I work
The mode of interaction depends on client needs:
- Bespoke technical advice to client only.
- Technical advice in Client/CRO meetings and interactions.
- Management of the complete activity at the CRO.